Page 3 - Dharmil Sheth News Today

As of December 2021, around 15+ startups announced their plans to float IPOs. Here’s a quick update on the current status of these IPOs.

In a majority of the cases, startup founders and cofounders are left with single-digit minority stakes and there are only a few exceptions.

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

PharmEasy parent API Holdings has received market regulator SEBI approval for its Rs 6,250 crore initial public offering (IPO).

The API Holdings IPO will entirely be a fresh issue with only a primary share sale of an unspecified number of shares worth ₹6,250 crore.

PharmEasy's parent company, API Holdings, has received clearance from SEBI to raise funds through an Initial Public Offering.

Amid apprehensions of volatility in the Indian stock market, online pharmacy PharmEasy is reportedly reconsidering its IPO valuation.

Fuelled by increasing internet penetration and smartphone use and loads of investor capital, in 2021, India saw a huge spike in the number of startups valued at over $1 billion—the unicorns. This is why they hogged the headlines - Issue Date: Jan 10, 2022

Unicorns are raining in India, thanks to an unprecedented funding spree for Indian startups across...

16 startups are expected to go public in 2022 out of which two have received SEBI’s approval and five DRHPs are yet to be approved.